Vietnamnet.vn
Podcast
Roche
Update news Roche
Roche lung cancer drug Alecensa slashes brain risk in tests
Patients taking Roche’s targeted lung cancer drug Alecensa have a far lower risk of their disease spreading in the brain than those on Pfizer’s Xalkori, new clinical trial data show.
Roche trial finds new drug cocktail cuts breast cancer deaths
Roche's bid to shield its ageing but lucrative oncology franchise from cheaper copies got a lift from a trial showing a new drug cocktail kept breast cancer patients alive longer.
Roche's lung cancer drug wins U.S. approval
Swiss drugmaker Roche Holding AG's new immunotherapy, Tecentriq, won approval on Tuesday from U.S. health regulators as a second-line lung cancer treatment,
Roche says FDA fast tracks atezolizumab in specific type of lung cancer
Roche Holding AG said on Monday the U.S. Food and Drug Administration has granted priority review for atezolizumab for treating people with a specific type of lung cancer.
